The GORUN Study: Gradual Onset of RUNning and Knee Joint Health in Novice Runners (GORUN)

April 7, 2026 updated by: Michael Hunt, University of British Columbia

Knee osteoarthritis (OA) is a debilitating disease affecting millions worldwide. Exercise is a core treatment for knee OA, and is advocated by all clinical guidelines. Running is a common exercise that is accessible and evokes a number of positive physical and psychological benefits. However, the appropriateness of recreational running in the presence of knee OA is unclear.

A growing literature base appears to suggest that running may not be deleterious to the health - especially at the knee joint - of people with knee OA. Our recent research has focused on examining a number of health outcomes relevant to knee OA in older individuals with knee OA, but has been limited to experienced runners. This study will address that limitation by focusing on how novice (new) runners respond to a new running program.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V6T 1Z3
        • Motion Analysis and Biofeedback Laboratory, The University of British Columbia
        • Contact:
        • Principal Investigator:
          • Michael A Hunt, PT, PhD
        • Sub-Investigator:
          • Jean-Francois Esculier, PT, PhD
        • Sub-Investigator:
          • Alexander Rauscher, PhD
        • Sub-Investigator:
          • Jacqueline Whittaker, PT, PhD
        • Sub-Investigator:
          • Jesse Charlton, PhD
        • Sub-Investigator:
          • Justin Losciale, PT, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria (all):

  • have been running consistently for no more than six months at time of enrolment, with a cumulative weekly volume of less than 5 kilometres OR have yet to take up recreational running consistently
  • are comfortable running and walking on a treadmill for at least 30 minutes

Inclusion criteria (knee osteoarthritis (OA) group):

  • have definitive knee OA as diagnosed using x-rays
  • report having experienced frequent knee pain over the past 3 months

Inclusion criteria (Control group):

  • have no evidence of knee OA based on x-rays
  • have had pain-free knees for at least the past 3 months

Exclusion Criteria (all):

  • have an inflammatory arthritic condition (e.g. gout or rheumatoid arthritis)
  • have a presence of any health condition (other than OA in the knee OA group) affecting normal movement or that precludes engaging in moderate to high impact activities such as running

Additionally, exclusion criteria based on MRI safety:

  • cannot safely fit into the MRI scanner
  • presence of metallic implants (including pace makers, brain aneurysm clips, stents, cochlear implants, artificial heart valves, and prostheses)
  • recent surgery or tattoos within the past 6 weeks
  • current or possible pregnancy
  • electrical stimulator for nerves or bones
  • infusion pumps
  • shrapnel or other metallic fragments
  • non-removable metallic jewellry

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Healthy control
Pain-free Individuals without radiographic evidence of knee osteoarthritis who will receive the running program intervention
Participants will receive a 6-month running program focusing on gradual increases in weekly running volume (no more than 5% per week, on average). For the purpose of this study, there will be no specific instructions on 'how' to run; rather, participants will simply be instructed on 'how much' to run.
Active Comparator: Knee osteoarthritis group
Individuals with knee pain and radiographic evidence of knee osteoarthritis who will receive the running program intervention
Participants will receive a 6-month running program focusing on gradual increases in weekly running volume (no more than 5% per week, on average). For the purpose of this study, there will be no specific instructions on 'how' to run; rather, participants will simply be instructed on 'how much' to run.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
T2 relaxation time - medial tibia
Time Frame: Baseline and 6 months
Magnetic resonance imaging (MRI) of the knee cartilage will be used to measure the exponential decay/dephasing of transverse magnetization of protons, known as T2 relaxation time (measured in milliseconds). Cartilage will be segmented into a number of regions of interest, with relaxation times calculated separately for each region of interest.
Baseline and 6 months
T2 relaxation time - medial femur
Time Frame: Baseline and 6 months
Magnetic resonance imaging (MRI) of the knee cartilage will be used to measure the exponential decay/dephasing of transverse magnetization of protons, known as T2 relaxation time (measured in milliseconds). Cartilage will be segmented into a number of regions of interest, with relaxation times calculated separately for each region of interest.
Baseline and 6 months
T2 relaxation time - patella
Time Frame: Baseline and 6 months
Magnetic resonance imaging (MRI) of the knee cartilage will be used to measure the exponential decay/dephasing of transverse magnetization of protons, known as T2 relaxation time (measured in milliseconds). Cartilage will be segmented into a number of regions of interest, with relaxation times calculated separately for each region of interest.
Baseline and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
T1rho relaxation time - medial tibia
Time Frame: Baseline and 6 months
Magnetic resonance imaging (MRI) of the knee cartilage will be used to assess the interaction between water and macromolecules. T1rho relaxation time (measured in milliseconds) measures how fast water protons spin-locked to macromolecules leave this locked state. Cartilage will be segmented into a number of regions of interest, with relaxation times calculated separately for each region of interest.
Baseline and 6 months
T1rho relaxation time - medial femur
Time Frame: Baseline and 6 months
Magnetic resonance imaging (MRI) of the knee cartilage will be used to assess the interaction between water and macromolecules. T1rho relaxation time (measured in milliseconds) measures how fast water protons spin-locked to macromolecules leave this locked state. Cartilage will be segmented into a number of regions of interest, with relaxation times calculated separately for each region of interest.
Baseline and 6 months
T1rho relaxation time - patella
Time Frame: Baseline and 6 months
Magnetic resonance imaging (MRI) of the knee cartilage will be used to assess the interaction between water and macromolecules. T1rho relaxation time (measured in milliseconds) measures how fast water protons spin-locked to macromolecules leave this locked state. Cartilage will be segmented into a number of regions of interest, with relaxation times calculated separately for each region of interest.
Baseline and 6 months
Knee Injury and Osteoarthritis Outcome Score (KOOS) - pain subscale
Time Frame: Baseline and 6 months
There are 9 questions in this subscale, with each question scored on a 5-point Likert scale ranging from "None" to "Extreme". The total sum of this subscale is calculated and divided by the maximum score to generate a score out of 100. Subscale totals range from 0 to 100, with higher scores indicating less pain.
Baseline and 6 months
Knee Injury and Osteoarthritis Outcome Score (KOOS) - function in daily living subscale
Time Frame: Baseline and 6 months
There are 17 questions in this subscale, with each question scored on a 5-point Likert scale ranging from "None" to "Extreme". The total sum of this subscale is calculated and divided by the maximum score to generate a score out of 100. Subscale totals range from 0 to 100, with higher scores indicating less pain.
Baseline and 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numerical rating scale of pain
Time Frame: Baseline and 6 months
11-point numerical rating scale; 0 = no pain; 10 = worst pain imaginable
Baseline and 6 months
Knee joint contact force impulse during running
Time Frame: Baseline and 6 months
3D motion capture technology will be used to measure joint motion trajectories and external forces applied to the lower limb during running. Musculoskeletal modelling techniques will be used to calculate the contact force within the tibiofemoral joint.
Baseline and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Hunt, PT, PhD, The University of British Columbia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Study Registration Dates

First Submitted

March 28, 2026

First Submitted That Met QC Criteria

April 7, 2026

First Posted (Actual)

April 14, 2026

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 7, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • H26-00511

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis (OA) of the Knee

Clinical Trials on Running volume increase

Subscribe